Relmada Therapeutics Inc’s filing revealed that its Chief Executive Officer TRAVERSA SERGIO acquired Company’s shares for reported $0.11 million on Dec 15 ’25. In the deal valued at $4.12 per share,27,500 shares were bought. As a result of this transaction, TRAVERSA SERGIO now holds 1,300,000 shares worth roughly $5.5 million.
Then, Shenouda Maged bought 11,665 shares, generating $48,060 in total proceeds. Upon buying the shares at $4.12, the Chief Financial Officer now owns 800,000 shares.
Before that, Shenouda Maged bought 500,000 shares. Relmada Therapeutics Inc shares valued at $1,100,000 were divested by the Chief Financial Officer at a price of $2.20 per share. As a result of the transaction, Shenouda Maged now holds 788,335 shares, worth roughly $3.33 million.
Jefferies initiated its Relmada Therapeutics Inc [RLMD] rating to a Buy in a research note published on December 22, 2025; the price target was $69. A number of analysts have revised their coverage, including Mizuho’s analysts, who increased its forecast for the stock in mid November from “a Neutral” to “an Outperform”. Mizuho also remained covering RLMD and has decreased its forecast on December 05, 2024 with a “Neutral” recommendation from previously “an Outperform” rating. Jefferies revised its rating on September 17, 2024. It rated RLMD as “a Buy” which previously was an “a Hold”.
Price Performance Review of RLMD
On Monday, Relmada Therapeutics Inc [NASDAQ:RLMD] saw its stock fall -3.20% to $4.23. Over the last five days, the stock has lost -6.21%. Relmada Therapeutics Inc shares have risen nearly 713.46% since the year began. Nevertheless, the stocks have fallen -12.42% over the past one year. While a 52-week high of $5.12 was reached on 01/02/26, a 52-week low of $0.24 was recorded on 01/05/26.
Levels Of Support And Resistance For RLMD Stock
The 24-hour chart illustrates a support level at 3.98, which if violated will result in even more drops to 3.73. On the upside, there is a resistance level at 4.48. A further resistance level may holdings at 4.73.
How much short interest is there in Relmada Therapeutics Inc?
A steep rise in short interest was recorded in Relmada Therapeutics Inc stocks on 2025-12-15, growing by 34225.0 shares to a total of 0.98 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 0.95 million shares. There was a rise of 3.49%, which implies that there is a positive sentiment for the stock.
